AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:41 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill DeMarco who wrote (464)	6/21/2003 8:12:41 AM
From: rrufff	Read Replies (2) of 513

Looks like this will be a hot one. It's tentatively going to be added to the Russell 3000 as of July 1, which means that there will be some extra publicity as well as portfolio adjustments. It's a thin float and could double from here very fast. CEO has indicated that funding is set for the next 2-3 years. From what I understand, they can adapt their technology to any area that is "hot", e.g. anthrax, SARS, etc., but that their initial money will be made in Cholera which is one of the deadly African epidemics.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next